Physician scientist, human geneticist and professor at Harvard Medical School.
Sekar Kathiresan, a physician scientist and a human geneticist, is the Director of the Center for Genomic Medicine (CGM) at Massachusetts General Hospital (MGH), Ofer and Shelly Nemirovsky MGH Research Scholar, Director of the Cardiovascular Disease Initiative at the Broad institute, and a Professor of Medicine at Harvard Medical School.
Dr. Kathiresan leverages human genetics to understand the root causes of heart attack and to improve preventive cardiac care. Among his scientific contributions, Dr. Kathiresan has helped highlight new biological mechanisms underlying heart attack, discovered mutations that protect against heart attack risk, and developed a genetic test for personalized heart attack prevention.
Visit website: http://www.kathiresanlab.org/about-sek/
See also: Harvard Medical School - Graduate medical school of Harvard University
Sekar Kathiresan News
Verve Therapeutics' gene editing therapy may cure heart attacks once and for all
Bloomberg - 06-May-2022
Trials underway to test the safety, but affordability and acceptance of gene therapy are major concernsRead more...
Gene editing lowered blood level cholesterol and triglycerides in monkeys
New York Times - 27-Jun-2020
Could prevent not only the complications but the heart disease per se in the futureRead more...
Crispr injection could reduce chance of heart attack
Guardian - 10-May-2019
Verve Therapeutics treatment targets PCSK9 geneRead more...